Legal Representation
Attorney
Jared M. Barrett
USPTO Deadlines
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 9, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jul 9, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 9, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 9, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 11, 2023 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
| Aug 11, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 10, 2023 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Aug 10, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Aug 9, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jul 26, 2023 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Jul 26, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 26, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 26, 2023 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Jul 11, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 16, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 16, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 26, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 12, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 4, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 16, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Aug 15, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 27, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of liver disease and monogenic disease; pharmaceutical preparations for the treatment of metabolic disorders, or central nervous system disorders; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Alport Syndrome; pharmaceutical preparations for the treatment of glomerulonephropathy; pharmaceutical preparations for the treatment of glomerulonephritis
Additional Information
Design Mark
The mark consists of a pathway through a center of a circle, the pathway dividing individual triangles in lighter shading that becomes darker toward the center on the left side of the pathway and darker shading that becomes lighter toward the bottom on the right side of the pathway.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005